Key result
Interleukin-2 complex cuts abdominal aortic aneurysm incidence by ~29 percentage points in mice.
Although regulatory T cells (Tregs) have been shown to play a protective role in abdominal aortic aneurysm (AAA) formation, it remains unclear whether expansion of endogenous Foxp3(+) Tregs prevents AAA. In the current study, we determined the effects of endogenous Foxp3(+) Treg expansion or depletion in an experimental model of AAA. We continuously infused 12-week-old apolipoprotein E-deficient mice fed a high-cholesterol diet with angiotensin II (n=60) or normal saline (n=12) by implanting osmotic mini-pumps and evaluated AAA formation at 16 weeks. The angiotensin II-infused mice received interleukin-2/anti-interleukin-2 monoclonal antibody complex (interleukin-2 complex; n=31) or PBS (n=29). Eighty-one percent of angiotensin II-infused mice developed AAA, with 42% mortality possibly because of aneurysm rupture. Interleukin-2 complex treatment systemically increased the number of Foxp3(+) Tregs and significantly decreased the incidence (52%) and mortality (17%) of AAA. Immunohistochemical analysis showed reduced accumulation of macrophages and increased numbers of Foxp3(+) Tregs in aneurysmal tissues, suggesting that expansion of Tregs may suppress local inflammation in the vessel wall and provide protection against AAA formation. Furthermore, genetic depletion of Foxp3(+) Tregs led to a significant increase in the mortality of AAA, suggesting the protective role of Foxp3(+) Tregs against AAA. Our findings suggest that Foxp3(+) Tregs may play a protective role in AAA formation and that promotion of an endogenous regulatory immune response may be a potentially valuable therapeutic approach for preventing AAA.
No takes yet. Share an insight, caveat, or question.
Yodoi et al. (2015) studied Angiotensin II-induced abdominal aortic aneurysm (AAA) in mice (n=72). Interleukin-2/anti-interleukin-2 monoclonal antibody complex (interleukin-2 complex) vs. PBS was evaluated on Abdominal aortic aneurysm (AAA) incidence. Interleukin-2 complex treatment expanding Foxp3(+) Tregs reduced AAA incidence from 81% to 52% and mortality from 42% to 17% in angiotensin II-infused mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: